Clinical Trial Update: On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating on-label intravitreal aflibercept injections for persistent pigment epithelial detachments in neovascular age-related m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Pigment Epithelial Detachment

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Tennessee Retina | Conditions: Age Related Macular Degeneration, Pigment Epithelial Detachment | Phase 4 | Status: UNKNOWN